Remi Rabasa-Lhoret, MD, PhD: Cystic Fibrosis Canada: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); FFRD: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); JDRF: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordik: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Avantis: Consultant/Advisory Board (Terminated), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated), Speaker/Honoraria (Terminated); Société Francophone du Diabète: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)